0001401708-20-000004.txt : 20200113 0001401708-20-000004.hdr.sgml : 20200113 20200113174737 ACCESSION NUMBER: 0001401708-20-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200109 FILED AS OF DATE: 20200113 DATE AS OF CHANGE: 20200113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GHESQUIERE DAVID W. CENTRAL INDEX KEY: 0001592508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 20524579 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wf-form4_157895563974892.xml FORM 4 X0306 4 2020-01-09 0 0001401708 NanoString Technologies Inc NSTG 0001592508 GHESQUIERE DAVID W. 530 FAIRVIEW AVENUE N SEATTLE WA 98109 0 1 0 0 SVP, Corporate & Business Dev Common Stock 2020-01-09 4 M 0 300 12.50 A 54469 D Common Stock 2020-01-09 4 S 0 300 29.0233 D 54169 D Common Stock 2020-01-10 4 M 0 19279 12.50 A 73448 D Common Stock 2020-01-10 4 S 0 19279 29.0698 D 54169 D Stock Option (right to buy) 12.5 2020-01-09 4 M 0 300 12.50 D 2023-12-04 Common Stock 300.0 92700 D Stock Option (right to buy) 12.5 2020-01-10 4 M 0 19279 12.50 D 2023-12-04 Common Stock 19279.0 73421 D The sales reported by Mr. Ghesquiere were effected pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2019. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. 25% of the shares subject to the Option vest on the one year anniversary of December 5, 2013 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option shall vest each monthly anniversary of the Vesting Commencement Date. /s/ Shannon Atchison, Attorney-in-fact 2020-01-13